Garofalo Health Care S.p.A. (BIT:GHC)
Italy flag Italy · Delayed Price · Currency is EUR
4.485
-0.020 (-0.44%)
At close: Mar 27, 2026

Garofalo Health Care Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
478.83462.18360.98314.76277.87
Other Revenue
8.255.595.165.285.06
487.08467.77366.14320.04282.93
Revenue Growth (YoY)
4.13%27.76%14.40%13.12%35.80%
Cost of Revenue
382.21367.94286.15251.39222.42
Gross Profit
104.8799.8379.9868.6560.51
Selling, General & Admin
-1.010.890.830.67
Other Operating Expenses
30.7723.7714.4713.7411.74
Operating Expenses
59.7250.1136.832.9327.93
Operating Income
45.1549.7243.1835.7232.58
Interest Expense
-11.81-13.93-10.29-4.2-4.21
Interest & Investment Income
0.551.070.280.020
Earnings From Equity Investments
0.080.120.170.130.21
Other Non Operating Income (Expenses)
0-0.71-0.46-0.24-0.25
EBT Excluding Unusual Items
33.9636.2832.8831.4328.34
Gain (Loss) on Sale of Investments
--0.02---
Gain (Loss) on Sale of Assets
-0.610.080.140.06
Asset Writedown
--0.83-1.67-0.6-0.19
Legal Settlements
--5.4-2.39-3.78-2.73
Pretax Income
33.9630.6928.9327.3725.48
Income Tax Expense
10.398.848.065.946.63
Earnings From Continuing Operations
23.5721.8520.8721.4318.84
Minority Interest in Earnings
-0.16-0.15-0.07-0.01-0.01
Net Income
23.4121.720.821.4318.83
Net Income to Common
23.4121.720.821.4318.83
Net Income Growth
7.87%4.34%-2.93%13.76%59.87%
Shares Outstanding (Basic)
9088898989
Shares Outstanding (Diluted)
9088898989
Shares Change (YoY)
1.77%-0.10%-0.40%-0.37%9.34%
EPS (Basic)
0.260.250.230.240.21
EPS (Diluted)
0.260.240.180.240.21
EPS Growth
8.33%33.33%-25.00%14.29%50.00%
Free Cash Flow
18.1216.734.5730.0413.12
Free Cash Flow Per Share
0.200.190.390.340.15
Dividend Per Share
0.0930.086---
Dividend Growth
8.14%----
Gross Margin
21.53%21.34%21.84%21.45%21.39%
Operating Margin
9.27%10.63%11.79%11.16%11.52%
Profit Margin
4.81%4.64%5.68%6.69%6.66%
Free Cash Flow Margin
3.72%3.57%9.44%9.38%4.64%
EBITDA
73.0570.9264.6254.0948.1
EBITDA Margin
15.00%15.16%17.65%16.90%17.00%
D&A For EBITDA
27.921.2121.4418.3615.52
EBIT
45.1549.7243.1835.7232.58
EBIT Margin
9.27%10.63%11.79%11.16%11.52%
Effective Tax Rate
30.61%28.80%27.85%21.69%26.04%
Revenue as Reported
487.08470.71368.7322.58283.67
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.